Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.

Pujol A, Hindelang C, Callizot N, Bartsch U, Schachner M, Mandel JL.

Hum Mol Genet. 2002 Mar 1;11(5):499-505.

2.

[X-linked adrenoleukodystrophy].

Aubourg P.

Ann Endocrinol (Paris). 2007 Dec;68(6):403-11. Epub 2007 May 29. Review. French.

PMID:
17532287
3.

ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations.

Kemp S, Pujol A, Waterham HR, van Geel BM, Boehm CD, Raymond GV, Cutting GR, Wanders RJ, Moser HW.

Hum Mutat. 2001 Dec;18(6):499-515. Review.

PMID:
11748843
4.

General aspects and neuropathology of X-linked adrenoleukodystrophy.

Ferrer I, Aubourg P, Pujol A.

Brain Pathol. 2010 Jul;20(4):817-30. doi: 10.1111/j.1750-3639.2010.00390.x. Review.

PMID:
20626743
5.

X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.

Kemp S, Wanders RJ.

Mol Genet Metab. 2007 Mar;90(3):268-76. Epub 2006 Nov 7. Review.

PMID:
17092750
6.

X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia?

Aubourg P, Dubois-Dalcq M.

Glia. 2000 Jan 15;29(2):186-90. Review. No abstract available.

PMID:
10625338
7.

X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.

Berger J, Gärtner J.

Biochim Biophys Acta. 2006 Dec;1763(12):1721-32. Epub 2006 Jul 26. Review.

8.

Cerebral inflammation in X-linked adrenoleukodystrophy.

McGuinness MC, Smith KD.

Arch Immunol Ther Exp (Warsz). 1999;47(5):281-7. Review.

PMID:
10604233
9.

X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.

Kemp S, Berger J, Aubourg P.

Biochim Biophys Acta. 2012 Sep;1822(9):1465-74. doi: 10.1016/j.bbadis.2012.03.012. Epub 2012 Mar 28. Review.

10.

Therapy of X-linked adrenoleukodystrophy.

Semmler A, Köhler W, Jung HH, Weller M, Linnebank M.

Expert Rev Neurother. 2008 Sep;8(9):1367-79. doi: 10.1586/14737175.8.9.1367. Review.

PMID:
18759549
11.

Biochemical aspects of X-linked adrenoleukodystrophy.

Kemp S, Wanders R.

Brain Pathol. 2010 Jul;20(4):831-7. doi: 10.1111/j.1750-3639.2010.00391.x. Review.

PMID:
20626744
12.

Adrenoleukodystrophy.

Cappa M, Bizzarri C, Vollono C, Petroni A, Banni S.

Endocr Dev. 2011;20:149-60. doi: 10.1159/000321236. Epub 2010 Dec 16. Review.

PMID:
21164268
13.

[Peroxisomal ABC transporters and X-linked adrenoleukodystrophy].

Geillon F, Trompier D, Gondcaille C, Lizard G, Savary S.

Med Sci (Paris). 2012 Dec;28(12):1087-94. doi: 10.1051/medsci/20122812019. Epub 2012 Dec 21. Review. French.

14.

Mutational analysis of X-linked adrenoleukodystrophy gene.

Takano H, Koike R, Onodera O, Tsuji S.

Cell Biochem Biophys. 2000;32 Spring:177-85. Review.

PMID:
11330045
15.

Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.

Singh I, Pujol A.

Brain Pathol. 2010 Jul;20(4):838-44. doi: 10.1111/j.1750-3639.2010.00392.x. Review.

16.

Pathophysiology of X-linked adrenoleukodystrophy.

Berger J, Forss-Petter S, Eichler FS.

Biochimie. 2014 Mar;98:135-42. doi: 10.1016/j.biochi.2013.11.023. Epub 2013 Dec 4. Review.

17.

Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.

Moser HW.

J Neuropathol Exp Neurol. 1995 Sep;54(5):740-5. Review.

PMID:
7666063
18.

Mouse models and genetic modifiers in X-linked adrenoleukodystrophy.

Heinzer AK, McGuinness MC, Lu JF, Stine OC, Wei H, Van der Vlies M, Dong GX, Powers J, Watkins PA, Smith KD.

Adv Exp Med Biol. 2003;544:75-93. Review. No abstract available.

PMID:
14713218
19.

Mutations in the adrenoleukodystrophy gene.

Dodd A, Rowland SA, Hawkes SL, Kennedy MA, Love DR.

Hum Mutat. 1997;9(6):500-11. Review.

PMID:
9195223
20.

[Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].

Morita M.

Yakugaku Zasshi. 2007 Jul;127(7):1059-64. Review. Japanese.

Items per page

Supplemental Content

Write to the Help Desk